Black Ginger Yields Two Novel Peptides That Quietly Switch Off the Skin’s Pigment Factory

Deep in the rhizomes of a Thai medicinal ginger known as black ginger, scientists have uncovered two short protein fragments that can dampen the enzyme driving excess skin pigmentation. The discovery, reported in the Journal of Agriculture and Food Research, transforms an underutilized plant protein stream into a candidate source of skin-lightening compounds, and offers a detailed mechanistic picture of how these molecules interfere with melanin production at the enzyme, cellular, and molecular levels. For a plant long prized for its flavonoids, the finding reveals a previously overlooked dimension of its chemistry.

The biological target is tyrosinase, the copper-containing enzyme that acts as the gatekeeper of melanogenesis, the biochemical pathway that produces melanin. Tyrosinase catalyzes two critical early steps: converting L-tyrosine into L-DOPA, and then oxidizing L-DOPA into dopaquinone, the precursor from which skin ultimately builds the dark pigments eumelanin and pheomelanin. Because this enzyme sits at the rate-limiting position of the pathway, blocking it has become the dominant strategy for treating hyperpigmentation disorders such as melasma, age spots, and freckles. Yet the current arsenal is imperfect. Hydroquinone, long considered the gold-standard depigmenting agent, carries risks of skin irritation and a disfiguring condition called exogenous ochronosis, and its use in cosmetics is restricted over carcinogenicity concerns. Arbutin and kojic acid are safer but less effective and notoriously unstable in formulation.

That gap has pushed researchers toward peptides, short chains of amino acids that can inhibit tyrosinase through several sequence-dependent routes: competing with substrate for the active site, chelating the copper ions the enzyme needs, or dialing down the genetic program that manufactures the pigment machinery in the first place. The team behind the new study, led by Papassara Sangtanoo and Piroonporn Srimongkol of Chulalongkorn University, reasoned that black ginger rhizomes, despite being a modest protein source, might harbor such peptides. Prior work had shown that the plant contains detectable endogenous peptides, and related species in the ginger family had already yielded tyrosinase-blocking sequences.

The researchers began by extracting crude protein from fresh rhizomes collected in Chiang Rai, Thailand, confirming the plant’s identity through herbarium authentication. They then deployed bromelain, a pineapple-derived enzyme prized for its mild processing conditions, to chop the protein into peptides. Screening revealed a striking size effect: the smaller the fragments, the stronger the inhibition. The fraction containing peptides below 0.65 kilodaltons suppressed tyrosinase with half-maximal inhibitory concentrations of roughly 3 milligrams per milliliter, an order of magnitude more potent than the crude protein itself. Reversed-phase chromatography on that fraction concentrated the activity further, with one sub-fraction showing inhibition at microgram-per-milliliter levels.

Mass spectrometry then delivered the payoff: two sequence-defined peptides, christened YQ-7 (YGRGPIQ) and YA-9 (YNYGPAGQA). Both begin with tyrosine, an aromatic residue that structural studies have repeatedly implicated in tyrosinase binding, and YA-9 carries two tyrosines to YQ-7’s one. When the team chemically synthesized both peptides and tested them against purified mushroom tyrosinase, the sequences retained their activity. YA-9 emerged as the stronger inhibitor, achieving an IC50 of 0.56 millimolar against the monophenolase reaction, while YQ-7 came in at 1.20 millimolar. Bioinformatic screening with the ToxinPred server predicted both peptides to be non-toxic, an encouraging early safety signal for cosmetic applications.

Enzyme kinetics revealed how the peptides work. Lineweaver-Burk analysis showed that increasing peptide concentrations raised the apparent Michaelis constant without changing the maximum reaction velocity, the classic signature of competitive inhibition. In other words, the peptides wedge themselves into the substrate-binding site, physically blocking L-tyrosine and L-DOPA access to the catalytic copper center. Molecular docking against the crystal structure of mushroom tyrosinase corroborated this picture, placing both peptides within the active-site pocket where they form hydrogen bonds with residues such as Asn260 and Arg268, hydrophobic contacts with Val283 and Leu275, and pi-stacking interactions with His263 and Phe264, all flanking the binuclear copper cluster.

The critical question was whether this enzyme-level activity translated into living cells. Testing in B16F10 melanoma cells, a standard model of constitutive melanogenesis, the team found that both peptides reduced intracellular tyrosinase activity and melanin content in a concentration-dependent manner, at levels where more than 80 percent of cells remained viable. At the highest dose of 500 micromolar, melanin content fell to roughly 73 percent of untreated levels for YQ-7 and 75 percent for YA-9. Gene expression analysis by quantitative PCR showed the strongest and most consistent suppression of the tyrosinase gene itself, and Western blotting confirmed concentration-dependent declines in tyrosinase and TRP-1 proteins, with YQ-7 driving tyrosinase protein down to about 23 percent of control levels at the highest dose.

Intriguingly, the molecular responses were not uniformly linear. TRP-2 protein levels fluctuated non-monotonically across concentrations, and MITF, the master transcription factor governing the melanogenic program, showed downward trends that never fell clearly below untreated levels. The authors interpret these inconsistencies as evidence that melanogenesis is controlled by layered, dose-sensitive regulatory networks, including the canonical MITF pathway and alternative routes such as p38 MAPK signaling, and caution that protein abundance, enzyme activity, and cumulative melanin represent distinct biological levels that need not change in lockstep. The findings suggest the peptides act both directly on the enzyme and more broadly on the cellular pigment machinery, though disentangling the relative contributions will require further pathway-specific work.

The final translational test came in zebrafish embryos, a transparent vertebrate model widely used to screen pigmentation modifiers. YA-9, chosen for its superior potency, proved remarkably safe: mortality stayed below 5 percent across all tested concentrations from 20 to 100 micromolar, with developmental abnormalities under 3 percent, against a toxic control that killed nearly 39 percent of embryos. But it failed to significantly lighten the embryos. Relative melanin content dropped only slightly, from a normalized value of 1.00 in controls to 0.81 at the highest dose, while the positive control phenylthiourea cut melanin to 0.58. The authors attribute this to a well-known limitation of immersion-based zebrafish assays: the chorion and vitelline membrane act as uptake barriers, and internal concentrations of a poorly water-soluble peptide like YA-9 may simply never reach the levels needed for visible depigmentation. Studies of small-molecule uptake in embryos have documented internal exposures five- to ninety-fold below nominal bath concentrations.

The upshot is a nuanced but genuinely promising result. YQ-7 and YA-9 are the first sequence-defined tyrosinase-inhibiting peptides isolated from black ginger, they retain activity in synthetic form, they competitively block the pigment enzyme’s active site through structurally coherent interactions, and they suppress basal melanogenesis in living cells without toxicity. Their zebrafish neutrality reflects a delivery problem rather than a failure of mechanism. The researchers propose that rational sequence refinement or novel delivery systems that enhance bioavailability could close the potency gap, positioning these black ginger peptides as a sustainable, plant-derived starting point for the next generation of skin-brightening actives.

Subject of Research: Novel tyrosinase inhibitory peptides from Kaempferia parviflora protein hydrolysate and their anti-melanogenic mechanisms in B16F10 cells and zebrafish

Article Title: Novel tyrosinase inhibitory peptides from Kaempferia parviflora protein hydrolysate with melanin suppression and mechanistic insights from B16F10 cells and zebrafish models

Article References: Sangtanoo, P., Kuptawach, K., Noitang, S., Saisavoey, T., Watsuntorn, W., Nutho, B., Reamtong, O., Ariyawansa, H. A., Karnchanatat, A., & Srimongkol, P. (2026). Novel tyrosinase inhibitory peptides from Kaempferia parviflora protein hydrolysate with melanin suppression and mechanistic insights from B16F10 cells and zebrafish models. Journal of Agriculture and Food Research, 31, Article 103357. https://doi.org/10.1016/j.jafr.2026.103357

Image Credits: AI Generated

DOI: 10.1016/j.jafr.2026.103357

Keywords: tyrosinase inhibition, Kaempferia parviflora, black ginger, bioactive peptides, melanogenesis, hyperpigmentation, B16F10 melanoma cells, molecular docking, competitive inhibition, zebrafish embryos, cosmetic ingredients, bromelain hydrolysis